Snapshot of the prescribing practice for the clopidogrel and esomeprazole coprescription and cost evaluation of the application guidelines

The antiplatelet clopidogrel and the proton pump inhibitor esomeprazole demonstrate a pharmacokinetic interaction through CYP2C19 that could translate into clinical inefficacy of clopidogrel. No medical consensus as to their coprescription has been reached, and different guidelines are available. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Vernaz, Nathalie, Rollason, Victoria, Adlere, Liene, Combescure, Christophe, Poncet, Antoine, Bonnabry, Pascal, Desmeules, Jules
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876144/
https://www.ncbi.nlm.nih.gov/pubmed/27433344
http://dx.doi.org/10.1002/prp2.234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876144/
https://www.ncbi.nlm.nih.gov/pubmed/27433344
http://dx.doi.org/10.1002/prp2.234

Ejemplares similares